Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 80.20 | NA | 15,246 | 80,577 | 80,313 | ||||||||||||
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 2.80 | NA | 378 | 2,814 | 2,806 | ||||||||||||
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 17.00 | NA | 3,899 | 17,084 | 16,264 |
DEMOGRAPHIC DETAILS OF DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 65,636 | 81.46 |
| Black | 7,895 | 9.8 |
| Hispanic | 1,878 | 2.33 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 26,176 | 32.49 |
| 70 to 74 | 19,429 | 24.11 |
| Less than 65 | 15,144 | 18.79 |
TOP ICD DIAGNOSIS CODES FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| V5811 | Encounter for antineoplastic chemotherapy | 45,345 | 56.28 |
| Z5111 | Encounter for antineoplastic chemotherapy | 34,278 | 42.54 |
| 4019 | Unspecified essential hypertension | 21,490 | 26.67 |
TOP ICD PROCEDURE CODES FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9925 | Injection Or Infusion Of Cancer Chemotherapeutic Substance | 43,211 | 53.63 |
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | 14,568 | 18.08 |
| 3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | 12,223 | 15.17 |
TOP HOSPITALS ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 3,542 | 4.4 |
| Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 1,171 | 1.45 |
| Massachusetts General Hospital | 55 FRUIT ST | Boston | MA | 02114 | 953 | 1.18 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 451 | 0.56 |
| DR. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 289 | 0.36 |
| DR. HUN JU LEE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 206 | 0.26 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 364 | 0.45 |
| DR. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 268 | 0.33 |
| DR. ARLENE O. SIEFKER-RADTKE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 214 | 0.27 |
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V5811 | Encounter for antineoplastic chemotherapy | NA | 45,345 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z5111 | Encounter for antineoplastic chemotherapy | 79,581 | 34,278 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 4019 | Unspecified essential hypertension | NA | 21,490 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | I10 | Essential (primary) hypertension | 21,475 | 16,660 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 2724 | Other and unspecified hyperlipidemia | NA | 11,660 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 20280 | Other malignant lymphomas, unspecified site, extranodal and solid organ sites | NA | 9,844 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | E785 | Hyperlipidemia, unspecified | 9,452 | 9,824 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V1582 | Personal history of tobacco use | NA | 9,798 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z87891 | Personal history of nicotine dependence | 11,849 | 9,787 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 25000 | Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled | NA | 8,192 |